Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis.

Matin GhanavatiYasaman KhorshidiMahdi ShadnoushMohammad Esmaeel AkbariSeyed Hossein ArdehaliYanin Chavarri-GuerraAtieh AkbariRegina Barragan-CarrilloManoochehr Amin AmlashiZeinab JavidJamal Rahmani

Published in: Cancer reports (Hoboken, N.J.) (2023)

This study highlights that tamoxifen use is a significant risk factor related to the incidence of EC in patients with BC.

Keyphrases

endometrial cancer
risk factors
systematic review
estrogen receptor
breast cancer cells
positive breast cancer
meta analyses
randomized controlled trial